Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy

Background: Immune checkpoint inhibitors (ICIs) represent a new therapeutic standard for an increasing number of tumor entities. Nevertheless, individual response and outcome to ICI is very heterogeneous, and the identification of the ideal ICI candidate has remained one of the major issues. Sarcope...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Loosen, Sven H., van den Bosch, Vincent, Gorgulho, Joao, Schulze-Hagen, Maximilian, Kandler, Jennis, Jördens, Markus S., Tacke, Frank, Loberg, Christina, Antoch, Gerald, Brümmendorf, Tim, Neumann, Ulf P., Kuhl, Christiane, Luedde, Tom, Roderburg, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036296/
https://ncbi.nlm.nih.gov/pubmed/33806224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10071361
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados